{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:28:02Z","timestamp":1758040082207,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1067\/mhj.2001.117032","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T17:24:11Z","timestamp":1034184251000},"page":"S9-S15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S","title":["Pentasaccharide Org31540\/SR90107A clinical trials update: Lessons for practice"],"prefix":"10.1067","volume":"142","author":[{"given":"Alexander G.G.","family":"Turpie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2001.117032_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1152\/ajplegacy.1918.47.3.328","article-title":"Two new factors in blood coagulation: heparin and pro-antithrombin","volume":"47","author":"Howell","year":"1918","journal-title":"Am J Physiol"},{"key":"10.1067\/mhj.2001.117032_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/ajplegacy.1939.125.4.683","article-title":"The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin","volume":"125","author":"Brinkhous","year":"1939","journal-title":"Am J Physiol"},{"key":"10.1067\/mhj.2001.117032_bib3","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM198805053181805","article-title":"Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery","volume":"318","author":"Collins","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.117032_bib4","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(60)92299-6","article-title":"Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial","volume":"1","author":"Barritt","year":"1960","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.117032_bib5","first-page":"162","article-title":"The anticoagulant from spoiled sweet clover hay: the Harvey Lectures: series XXXIX","author":"Link","year":"1944"},{"key":"10.1067\/mhj.2001.117032_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000441-194110000-00009","article-title":"Studies on the hemorrhagic agent 3,3\u2019\u2013methylenebis (4-hydroxycoumarin). I: its effect on the prothrombin and coagulation time of the blood of dogs and humans","volume":"202","author":"Bingham","year":"1941","journal-title":"Am J Med Sci"},{"key":"10.1067\/mhj.2001.117032_bib7","first-page":"388","article-title":"A preparation from spoiled sweet clover [3,3\u2019-methylene-bis-(4-hydroxycoumarin)] which prolongs coagulation and prothrombin time of the blood: preliminary report of experimental and clinical studies","volume":"16","author":"Butt","year":"1941","journal-title":"Proceedings of the Staff Meetings of the Mayo Clinic"},{"key":"10.1067\/mhj.2001.117032_bib8","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.93.12.2212","article-title":"Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals from the Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association","volume":"93","author":"Hirsh","year":"1996","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.117032_bib9","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM199506223322501","article-title":"A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism","volume":"332","author":"Schulman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.117032_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archinte.1995.00430040034004","article-title":"Starting prophylaxis for venous thromboembolism postoperatively","volume":"155","author":"Kearon","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1067\/mhj.2001.117032_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3466.1997.tb00321.x","article-title":"SR 90107A\/Org 31540, a novel anti-factor Xa antithrombotic agent","volume":"15","author":"Herbert","year":"1997","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1067\/mhj.2001.117032_bib12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1021\/jm960726z","article-title":"Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A\/ORG 31540)","volume":"40","author":"Petitou","year":"1997","journal-title":"J Med Chem"},{"key":"10.1067\/mhj.2001.117032_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-2318(08)60067-0","article-title":"Structure and biological activity of heparin","volume":"43","author":"Casu","year":"1985","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"10.1067\/mhj.2001.117032_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-996063","article-title":"Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes","volume":"23","author":"Bianchini","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1067\/mhj.2001.117032_bib15","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.1016\/S0021-9258(18)42309-5","article-title":"Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement","volume":"267","author":"Olson","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1067\/mhj.2001.117032_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0006-291X(83)90550-8","article-title":"Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity","volume":"116","author":"Choay","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1067\/mhj.2001.117032_bib17","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/(SICI)1521-3773(19981116)37:21<3009::AID-ANIE3009>3.0.CO;2-F","article-title":"First synthetic carbohydrates with the full anticoagulant properties of heparin","volume":"37","author":"Petitou","year":"1998","journal-title":"Angewandte Chemie, International Edition"},{"key":"10.1067\/mhj.2001.117032_bib18","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/anie.199316713","article-title":"The unique antithrombin III binding domain of heparin: a lead to new synthetic antithrombotics","volume":"32","author":"van Boeckel","year":"1993","journal-title":"Angewandte Chemie, International Edition in English"},{"key":"10.1067\/mhj.2001.117032_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0049-3848(88)90128-4","article-title":"Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activity","volume":"52","author":"Walenga","year":"1988","journal-title":"Thromb Res"},{"issue":"9","key":"10.1067\/mhj.2001.117032_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM200103013440901","article-title":"A synthetic pentasaccharide for the prevention of thrombosis after total hip replacement","volume":"344","author":"Turpie","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.117032_bib21","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.CIR.102.22.2726","article-title":"Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A\/ORG31540) with pure anti-factor Xa activity: a phase II evaluation","volume":"102","author":"Rembrandt Investigators","year":"2000","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301262474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301262474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:48:05Z","timestamp":1757569685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870301262474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0002870301262474"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2001.117032","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentasaccharide Org31540\/SR90107A clinical trials update: Lessons for practice","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mhj.2001.117032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}